Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis
Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis. // Taiwanese Journal of Obstetrics & Gynecology. – URL: https://www.sciencedirect.com/science/article/pii/S102845592600272X?dgcid=rss_sd_all
Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis. Taiwanese Journal of Obstetrics & Gynecology. https://www.sciencedirect.com/science/article/pii/S102845592600272X?dgcid=rss_sd_all
“Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis.” Taiwanese Journal of Obstetrics & Gynecology.
@article{article117751,
title = {Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis},
journal = {Taiwanese Journal of Obstetrics \& Gynecology},
url = {https://www.sciencedirect.com/science/article/pii/S102845592600272X?dgcid=rss_sd_all}
}
ABSTRACT Introduction Postpartum hemorrhage (PPH) has significant short‐ and long‐term effects for women. Research typically focuses on women who experience severe bleeding. Little is known about women's understanding of their risk or...